Akiyama, Saeko
Saku, Noriaki
Miyata, Shoko
Ite, Kenta
Toyoda, Masashi
Kimura, Tohru
Kuroda, Masahiko
Nakazawa, Atsuko
Kasahara, Mureo
Nonaka, Hidenori
Kamiya, Akihide
Kiyono, Tohru
Kobayshi, Tohru
Murakami, Yasufumi
Umezawa, Akihiro
Funding for this research was provided by:
National Center for Child Health and Development
AMED
KAKENHI
Article History
Received: 3 September 2021
Accepted: 14 February 2022
First Online: 12 March 2022
Declarations
:
: Human cells in this study were performed in full compliance with the Ethical Guidelines for Clinical Studies (Ministry of Health, Labor, and Welfare, Japan). The cells were banked after approval of the Institutional Review Board at the National Institute of Biomedical Innovation (May 9, 2006). Animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of the National Research Institute for Child Health and Development.
: Informed consent for publication was obtained from the patient's parents.
: AU is a co-researcher with MTI Ltd., Terumo Corp., BONAC Corp., Kaneka Corp., CellSeed Inc., ROHTO Pharmaceutical Ltd., SEKISUI MEDICAL Ltd., Metcela Inc., PhoenixBio Ltd., Dai Nippon Printing Ltd. AU is a stockholder of TMU Science Ltd., Morikuni Ltd. and Japan Tissue Engineering Ltd. AU is the associate editor of the journal and was not involved in the peer review process of the article. The other authors declare that there is no conflict of interest regarding the work described herein.